cannabis-grand-rounds-header
Cannabis Grand Rounds is produced by healthcare professionals for healthcare professionals to provide accurate and unbiased education on all things cannabis. The show is hosted by Drs. Matthews, Vinocur and Altman, who are all physicians with Masters Degrees in medical cannabis science and therapeutics from the University of Maryland School of Pharmacy. The Podcast accepts no external funding or advertising.

Can Cannabis Mitigate the Need for Opiates in Treating Pain? feat. Dr. Andrew Coop

From the Show: Cannabis Grand Rounds
Summary: It is no question that we need new ways and medications to manage pain outside of opiates.
Air Date: 6/13/22
Duration: 25:24
Guest Bio: Dr. Andrew Coop
Dr. Andrew Coop received his Ph.D. from the University of Bristol in the area of chemistry of drugs of abuse, followed by a Fogerty post-doctoral fellowship at the National Institutes of Health. He has been a faculty member in the Department of Pharmaceutical Sciences since 1999, serving as chair of the department from 2007-2015. His NIH-funded research area focuses on the design and synthesis of new opioid analgesics with the reduced tolerance, and the development of novel antidepressants.
Can Cannabis Mitigate the Need for Opiates in Treating Pain? feat. Dr. Andrew Coop
It is no question that we need new ways and medications to manage pain outside of opiates. Could cannabis be the solution?

Dr. Andrew Coop is joining us again this episode to talk about THC isomeres. Dr. Coop received his Ph.D. from the University of Bristol in the area of chemistry of drugs of abuse, followed by a Fogerty post-doctoral fellowship at the National Institutes of Health. He has been a faculty member in the Department of Pharmaceutical Sciences at the University of Maryland since 1999, serving as chair of the department from 2007 to 2015.

Today Dr. Coop sits down with Dr. Hal Altman MD, MS, and talks about his testimony to the United States Senate Committee on Health, Education, Labor and Pensions (HELP), his mentor John Lewis, and where cannabinoids could fit into pain management practices.